Medicare Enrolled
Dr. Hitesh Patel, M.D.
Hematology · Clearwater, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Hitesh Patel is a hematology specialist in Clearwater, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 162,506 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patel received a total of $14,614 from 99 pharmaceutical and/or device companies across 698 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 31% volume in FL
$14,614 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 59034 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗162,506
Medicare services
Top 31% in FL for hematology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
79,050 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
42,420 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
13,980 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 7,800 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,540 | $18 | $51 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,158 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,998 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,531 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,270 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
806 | $10 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
751 | $96 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 632 | $0 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
567 | $65 | $239 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
450 | $22 | $84 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
441 | $97 | $378 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
318 | $47 | $189 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
198 | $15 | $56 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
187 | $12 | $61 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
135 | $10 | $42 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
124 | $54 | $206 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
123 | $26 | $89 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
121 | $48 | $178 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
121 | $1 | $3 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
102 | $17 | $59 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
92 | $27 | $156 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
89 | $3 | $11 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
86 | $22 | $79 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
83 | $1 | $6 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
68 | $2 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $134 | $562 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $125 | $453 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $80 | $298 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
34 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $138 | $474 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
19 | $25 | $156 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
17 | $1 | $7 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
16 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
49.6% high complexity
47.0% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,614
Total received (2018-2024)
Avg $2,088/year across 7 years
Top 34% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
698
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,138
2023
$1,981
2022
$1,784
2021
$1,911
2020
$1,570
2019
$1,652
2018
$1,578
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,284
PFIZER INC.
$597
AstraZeneca Pharmaceuticals LP
$234
GENZYME CORPORATION
$133
Merck Sharp & Dohme LLC
$123
Janssen Biotech, Inc.
$118
Takeda Pharmaceuticals U.S.A., Inc.
$114
ABBVIE INC.
$106
Celgene Corporation
$106
E.R. Squibb & Sons, L.L.C.
$90
Regeneron Healthcare Solutions, Inc.
$90
Daiichi Sankyo Inc.
$80
Pharmacosmos Therapeutics Inc.
$76
Incyte Corporation
$66
Exelixis Inc.
$64
Gilead Sciences, Inc.
$61
Genmab U.S., Inc.
$59
GlaxoSmithKline, LLC.
$56
ARRAY BIOPHARMA INC
$55
Astellas Pharma US Inc
$54
Lilly USA, LLC
$51
SOBI, INC
$49
Tempus AI, Inc
$41
Eisai Inc.
$39
TerSera Therapeutics LLC
$39
CSL Behring
$38
Dendreon Pharmaceuticals LLC
$35
Genentech USA, Inc.
$30
Stemline Therapeutics Inc.
$29
SpringWorks Therapeutics, Inc.
$28
Blueprint Medicines Corporation
$28
BeiGene USA, Inc.
$26
PUMA BIOTECHNOLOGY, INC.
$23
Aveo Pharmaceuticals, Inc.
$21
Agios Pharmaceuticals, Inc.
$21
Sumitomo Pharma America, Inc.
$20
Alexion Pharmaceuticals, Inc.
$19
TAIHO ONCOLOGY, INC.
$18
SHIELD THERAPEUTICS INC
$14
Rigel Pharmaceuticals, Inc.
$6
Top 3 companies account for 51.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,828
AstraZeneca Pharmaceuticals LP
$895
PFIZER INC.
$721
Janssen Biotech, Inc.
$609
GENZYME CORPORATION
$602
Lilly USA, LLC
$493
E.R. Squibb & Sons, L.L.C.
$490
Seagen Inc.
$465
Merck Sharp & Dohme Corporation
$455
Celgene Corporation
$440
Daiichi Sankyo Inc.
$432
Genentech USA, Inc.
$420
Amgen Inc.
$361
Incyte Corporation
$324
Gilead Sciences, Inc.
$297
Astellas Pharma US Inc
$276
Bayer HealthCare Pharmaceuticals Inc.
$253
Eisai Inc.
$244
Takeda Pharmaceuticals U.S.A., Inc.
$243
GlaxoSmithKline, LLC.
$216
Merck Sharp & Dohme LLC
$201
Exelixis Inc.
$189
ABBVIE INC.
$175
Regeneron Healthcare Solutions, Inc.
$170
CSL Behring
$156
TerSera Therapeutics LLC
$154
EMD Serono, Inc.
$146
Kite Pharma, Inc.
$131
TESARO, Inc.
$126
BeiGene USA, Inc.
$125
Ipsen Biopharmaceuticals, Inc
$120
SANOFI-AVENTIS U.S. LLC
$112
Janssen Pharmaceuticals, Inc
$107
Genmab U.S., Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
PUMA BIOTECHNOLOGY, INC.
$84
AbbVie, Inc.
$80
Agios Pharmaceuticals, Inc.
$77
Pharmacosmos Therapeutics Inc.
$76
Karyopharm Therapeutics Inc.
$76
Foundation Medicine, Inc.
$72
Kyowa Kirin, Inc.
$71
AMAG Pharmaceuticals, Inc.
$67
Stemline Therapeutics Inc.
$67
EISAI INC.
$65
Pharmacyclics LLC, an AbbVie Company
$64
SOBI, INC
$64
GE HEALTHCARE
$62
Pharmacyclics LLC, An AbbVie Company
$61
Sumitomo Pharma America, Inc.
$57
ARRAY BIOPHARMA INC
$55
Myovant Sciences Inc.
$53
Dendreon Pharmaceuticals LLC
$52
Deciphera Pharmaceuticals Inc.
$49
G1 Therapeutics, Inc.
$46
Dova Pharmaceuticals
$45
Lexicon Pharmaceuticals, Inc.
$45
Rigel Pharmaceuticals, Inc.
$44
Array BioPharma Inc.
$43
PharmaEssentia USA Corporation
$42
Tempus AI, Inc
$41
Blueprint Medicines Corporation
$39
AbbVie Inc.
$38
MorphoSys, US Inc.
$36
Shire North American Group Inc
$36
Epizyme, Inc.,
$36
Taiho Oncology, Inc.
$33
Aveo Pharmaceuticals, Inc.
$32
MEDIVATION FIELD SOLUTIONS LLC
$32
ADC Therapeutics America, Inc.
$32
Alexion Pharmaceuticals, Inc.
$31
AVEO Pharmaceuticals, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$30
Sun Pharmaceutical Industries Inc.
$30
SpringWorks Therapeutics, Inc.
$28
Seattle Genetics, Inc.
$27
Sirtex Medical Inc
$26
Clovis Oncology, Inc.
$26
Myriad Genetic Laboratories, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
TG THERAPEUTICS, INC.
$21
Puma Biotechnology, Inc.
$20
INSYS Therapeutics Inc
$18
Mirati Therapeutics, Inc.
$18
TAIHO ONCOLOGY, INC.
$18
CTI BioPharma Corp.
$17
Immunomedics, Inc.
$16
Jazz Pharmaceuticals Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
Adaptive Biotechnologies Corporation
$16
Acceleron Pharma, Inc.
$15
Verity Pharmaceuticals Inc.
$15
Servier Pharmaceuticals LLC
$15
Acrotech Biopharma LLC
$14
Verastem, Inc.
$14
SHIELD THERAPEUTICS INC
$14
Sobi, Inc
$12
Aurobindo Pharma USA, Inc.
$12
Top 3 companies account for 23.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FASENRA · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Idelvion · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kcentra · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MARQIBO · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
40
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
MORTON PLANT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Patel performed 79,050 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $14,614 from 99 companies across 698 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematologists in Clearwater?
Dr. Patel's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Clearwater
Browse hematologists in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology